Literature DB >> 8513896

NADH-cytochrome b5 reductase and cytochrome b5 isoforms as models for the study of post-translational targeting to the endoplasmic reticulum.

N Borgese1, A D'Arrigo, M De Silvestris, G Pietrini.   

Abstract

Cytochrome b5 and NADH-cytochrome b5 reductase are integral membrane proteins with cytosolic active domains and short membrane anchors, which are inserted post-translationally into their target membranes. Both are produced as different isoforms, with different localizations, in mammalian cells. In the rat, the reductase gene generates two transcripts by an alternative promoter mechanism: a ubiquitous mRNA coding for the myristylated membrane-bound form, and an erythroid mRNA which generates both the soluble form and a nonmyristylated membrane-binding form. The available evidence indicates that the ubiquitous myristylated form binds to the cytosolic face of both outer mitochondrial membranes and ER. In contrast, two genes code for two homologous forms of cytochrome b5, one of which is found on outer mitochondrial membranes, the other on the ER. The gene specifying the ER form probably also generates an erythroid-specific mRNA by alternative splicing, which codes for soluble cytochrome b5. Possible molecular mechanisms responsible for the observed localizations of these different enzyme isoforms are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8513896     DOI: 10.1016/0014-5793(93)81416-w

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

1.  Microsomal electron transfer in higher plants: cloning and heterologous expression of NADH-cytochrome b5 reductase from Arabidopsis.

Authors:  M Fukuchi-Mizutani; M Mizutani; Y Tanaka; T Kusumi; D Ohta
Journal:  Plant Physiol       Date:  1999-01       Impact factor: 8.340

Review 2.  Metalloproteins containing cytochrome, iron-sulfur, or copper redox centers.

Authors:  Jing Liu; Saumen Chakraborty; Parisa Hosseinzadeh; Yang Yu; Shiliang Tian; Igor Petrik; Ambika Bhagi; Yi Lu
Journal:  Chem Rev       Date:  2014-04-23       Impact factor: 60.622

3.  Reductive detoxification of arylhydroxylamine carcinogens by human NADH cytochrome b5 reductase and cytochrome b5.

Authors:  Joseph R Kurian; Nathaniel A Chin; Brett J Longlais; Kristie L Hayes; Lauren A Trepanier
Journal:  Chem Res Toxicol       Date:  2006-10       Impact factor: 3.739

4.  Molecular basis of two novel mutations found in type I methemoglobinemia.

Authors:  Felipe R Lorenzo; John D Phillips; Roberto Nussenzveig; Bindu Lingam; Parvaiz A Koul; Stanley L Schrier; Josef T Prchal
Journal:  Blood Cells Mol Dis       Date:  2011-02-24       Impact factor: 3.039

Review 5.  The mammalian molybdenum enzymes of mARC.

Authors:  Gudrun Ott; Antje Havemeyer; Bernd Clement
Journal:  J Biol Inorg Chem       Date:  2014-11-26       Impact factor: 3.358

6.  Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes.

Authors:  Jay D Horton; Nila A Shah; Janet A Warrington; Norma N Anderson; Sahng Wook Park; Michael S Brown; Joseph L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-25       Impact factor: 11.205

7.  GGPP depletion initiates metaflammation through disequilibrating CYB5R3-dependent eicosanoid metabolism.

Authors:  Lisha Wei; Yan-Yan Zheng; Jie Sun; Pei Wang; Tao Tao; Yeqiong Li; Xin Chen; Yongjuan Sang; Danyang Chong; Wei Zhao; Yuwei Zhou; Ye Wang; Zhihui Jiang; Tiantian Qiu; Chao-Jun Li; Min-Sheng Zhu; Xuena Zhang
Journal:  J Biol Chem       Date:  2020-09-10       Impact factor: 5.157

8.  Tobacco cytochrome b5: cDNA isolation, expression analysis and in vitro protein targeting.

Authors:  M A Smith; A K Stobart; P R Shewry; J A Napier
Journal:  Plant Mol Biol       Date:  1994-06       Impact factor: 4.076

9.  Evolutionary divergence of the cytochrome b5 gene of Drosophila.

Authors:  M E Kula; E R Allay; C E Rozek
Journal:  J Mol Evol       Date:  1995-10       Impact factor: 2.395

Review 10.  Plant-based strategies aimed at expressing HIV antigens and neutralizing antibodies at high levels. Nef as a case study.

Authors:  Carla Marusic; Alessandro Vitale; Emanuela Pedrazzini; Marcello Donini; Lorenzo Frigerio; Ralph Bock; Philip J Dix; Matthew S McCabe; Michele Bellucci; Eugenio Benvenuto
Journal:  Transgenic Res       Date:  2009-01-25       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.